Peptide-Based Treatment: A Promising Cancer Therapy

Area of Science:

• Oncology
• Biochemistry
• Nanotechnology

Background:

• Peptide-based chemotherapy is emerging as a significant cancer treatment modality.
• Peptides offer advantages like low molecular weight, tumor-targeting specificity, and reduced toxicity to normal tissues.

Purpose of the Study:

• To review recent advancements in peptide applications for cancer treatment.
• To cover peptide-based diagnosis, therapy, and prognosis in oncology.

Main Methods:

• Review of current literature on peptide-based cancer therapies.
• Categorization of peptide therapies into peptide-alone, peptide vaccines, and peptide-conjugated nanomaterials.

Main Results:

• Peptide-alone therapy can enhance anti-tumor immune responses.
• Peptide vaccines have shown improved survival rates in advanced cancers.
• Peptide-nanomaterial conjugates improve drug delivery and sensitivity.

Conclusions:

• Peptides represent a versatile platform for novel cancer therapies.
• Integration of peptides with diagnostics and advanced delivery systems shows great potential.
• Further research into peptide applications could significantly impact cancer care.